Nagi Bioscience is among the 20 finalists of the competition “Inventer Demain” organized by the RTS, France 3TV and Bilan magazine. Ten Swiss start-ups and ten other French companies are competing this year. This international competition aims to support entrepreneurs and startups in both countries, by shining the spotlight on ideas, pathways, discoveries and applications that couldRead more about Our startup is finalist of the competition “Inventer Demain”[…]
We are proud to be the winner (CHF 10’000 cash prize) of the startup competition organized by Philip Morris Equity Partner! This competition, organized in the framework of MassChallenge Switzerland, aimed to support innovative business which could have an impact on PMI’s value chain and its smoke free future vision. You can read the article publishedRead more about Nagi Bioscience won the Philip Morris Award Startup Competition![…]
Nagi Bioscience passed stage 2 of Venture Kick! Let’s continue on our way: stage 3, here we come!
Nagi Bioscience is featured today in the online version of French Economic TV channel BFMTV. This article (in French) introduces the technology developed by our startup and its application for avoiding testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!
Nagi Bioscience is featured today in the Economic Swiss newspaper Bilan. This article (in French) presents our startup and its device that avoids testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!
We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge SwitzerlandRead more about Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program[…]
Matteo and Laurent appeared respectively in two radio show broadcasted on the Swiss Radio RTS. They discuss the today’s problematic of animal testing and how the technology developed by Nagi Bioscience can bring an innovative solution to solve this issue. You can listen the live interview of Matteo and Laurent here and here (in French).
Our CSO Laurent Mouchiroud received the prestigious PERL (Prix Entreprendre Région Lausanne) Biotech Award 2018 during a ceremony held at the Theatre de Beaulieu in Lausanne. Each year, the PERL jury, made up of academic, economic and media representatives, is responsible for selecting and nominate the laureates. These laureates will benefit, before and after the prize-givingRead more about Nagi Bioscience won the PERL Biotech Award 2018[…]
An interview with Matteo Cornaglia, our CEO, was published on te front page of the EPFL website, providing some insight about the how and why of the technology developed by Nagi Bioscience. You can see the video entitled “Tech-Transfer:worms in high-tech housing replace laboratory mice” here.
Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business development training based in the Boston, US. In the context of the program, he is going to pitch at the Startup ChampionsRead more about Matteo was selected for Venture Leaders Life Sciences 2018[…]